Overslaan en naar de inhoud gaan

 Wetenschapelijke artikelen

Evaluation of the Comprehensive Geriatric Assessment (CGA) tool as a predictor of postoperative complications following major oncological abdominal surgery in geriatric patients.

Auteurs : Penning Y, El Asmar A, Moreau M, Raspé J, Dal Lago L, Pepersack T, Donckier V, Liberale G
Jaar : 2022
Journal : PLoS One
Volume : 17
Pagina's : e0264790

Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial.

Auteurs : Dal Lago L, Uwimana AL, Coens C, Vuylsteke P, Curigliano G, Brouwers B, Jagiello-Gruszfeld A, Altintas S, Tryfonidis K, Poncet C, Bottomley A, Sousa B, Brain E, Wildiers H
Jaar : 2022
Journal : J Geriatr Oncol

The Managing Advanced Cancer Pain Together (MACPT) conversation tool: an evaluation of use in clinical practice.

Auteurs : Quinn B, Laurent S, Dargan S, Lapuente M, Lüftner D, Drudge-Coates L, Palma MD, Dal Lago L, Flynn J, Panter C, Seesaghur A
Jaar : 2022
Journal : Pain Manag
Volume : 12
Pagina's : 435-446

Frailty in older adults with cancer (Fabio Gomez, editor) - Part III : Breast cancer in older adults with frailty

Auteurs : Dal Lago L, De Caluwe A, Borghgraef C, Dumont L, Pepersack T
Jaar : 2022
Journal : Book
Volume : part III
Pagina's : 303 - 318

Correction to: Tolerability and toxicity of trastuzumab or trastuzumab?+?lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D).

Auteurs : Pondé N, Agbor-Tarh D, Dal Lago L, Korde LA, Hilbers F, Jackisch C, Werner O, Gelber Rd, Jatoi A, Dueck AC, Moreno-Aspitia A, Sotiriou C, de Azambuja E, Piccart-Gebhart M
Jaar : 2021
Journal : Breast Cancer Res Treat

Sarcoidosis Versus Lymphoma?

Auteurs : Dal Lago L, Sarrand J, Woff E, Awada A, Vouche M, Pepersack T
Jaar : 2021
Journal : Eur J Case Rep Intern Med
Volume : 8
Pagina's : 002250

Tolerability and toxicity of trastuzumab or trastuzumab?+?lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D).

Auteurs : Pondé N, Agbor-Tarh D, Dal Lago L, Korde LA, Hilbers F, Jackisch C, Werner O, Gelber Rd, Jatoi A, Dueck AC, Moreno-Aspitia A, Sotiriou C, de Azambuja E, Piccart-Gebhart M
Jaar : 2021
Journal : Breast Cancer Res Treat
Volume : 185
Pagina's : 107-116

Targeted agents in older patients with gastrointestinal cancers - An overview.

Auteurs : Monteiro AR, Conde RS, Basto R, Sclafani F, Deleporte A, Hendlisz A, Dal Lago L
Jaar : 2021
Journal : J Geriatr Oncol
Volume : 12
Pagina's : 1240-1252

Prostate Cancer and Reactive Haemophagocytic Lymphohistiocytosis.

Auteurs : Dumont L, Salaroli A, Dal Lago L, Gil T, Pepersack T
Jaar : 2021
Journal : Eur J Case Rep Intern Med
Volume : 8
Pagina's : 002425

Rare Features of Dermatomyositis in a Patient with Ovarian Cancer.

Auteurs : Dal Lago L, Vandergheynst F, Awada A, Pepersack T
Jaar : 2020
Journal : Eur J Case Rep Intern Med
Volume : 7
Pagina's : 001946

The added value of geriatric assessment in evaluating a patient's Health-Related Quality-of-Life: A study in ≥70-year-old early-stage invasive breast cancer patients.

Auteurs : Quinten C, Kenis C, Hamaker M, Coolbrandt A, Brouwers B, Dal Lago L, Neven P, Vuylsteke P, Debrock G, Van den Bulck H, Smeets A, Schöffski P, Wedding U, Wildiers H
Jaar : 2020
Journal : Eur J Cancer Care (Engl)
Volume : 29
Pagina's : e13278

Use of granulocyte-colony stimulating factors in older patients: a review of recently published data.

Auteurs : Klastersky J, Dal Lago L, Lalami Y
Jaar : 2020
Journal : Curr Opin Oncol
Volume : 32
Pagina's : 258-261

Anti-HER2 therapy for breast cancer in older patients.

Auteurs : Goldner M, Franzoi MA, Dal Lago L, Pondé N
Jaar : 2020
Journal : Future Oncol
Volume : 16
Pagina's : 1393-1407

Targeted therapy for breast cancer in older patients.

Auteurs : Pondé N, Wildiers H, Awada A, de Azambuja E, Deliens C, Dal Lago L
Jaar : 2020
Journal : J Geriatr Oncol
Volume : 11
Pagina's : 380-388

HER2-targeted treatment for older patients with breast cancer: An expert position paper from the International Society of Geriatric Oncology.

Auteurs : Brain E, Caillet P, de Glas N, Biganzoli L, Cheng K, Dal Lago L, Wildiers H
Jaar : 2019
Journal : J Geriatr Oncol
Volume : 10
Pagina's : 1003-1013

Advances in pain management for older patients with cancer.

Auteurs : Hachem GE, Rocha FO, Pepersack T, Jounblat Y, Drowart A, Dal Lago L
Jaar : 2019
Journal : Ecancermedicalscience
Volume : 13
Pagina's : 980

Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.

Auteurs : Wildiers H, Tryfonidis K, Dal Lago L, Vuylsteke P, Curigliano G, Waters S, Brouwers B, Altintas S, Touati N, Cardoso F, Brain E
Jaar : 2018
Journal : Lancet Oncol
Volume : 19
Pagina's : 323-336

The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged =70 with early stage invasive breast cancer.

Auteurs : Quinten C, Kenis C, Hamaker M, Coolbrandt A, Brouwers B, Dal Lago L, Neven P, Vuylsteke P, Debrock G, Van den Bulck H, Smeets A, Schöffski P, Bottomley A, Wedding U, Wildiers H
Jaar : 2018
Journal : J Geriatr Oncol
Volume : 9(2)
Pagina's : 152-162

Characterization of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.

Auteurs : Cardoso F, Bartlett JMS, Slaets L, van Deurzen CHM, van Leeuwen-Stok E, Porter P, Linderholm B, Hedenfalk I, Schröder C, Martens J, Bayani J, van Asperen C, Murray M, Hudis C, Middleton L, Vermeij J, Punie K, Fraser J, Nowaczyk M, Rubio IT, Aebi S, Kelly C, Ruddy KJ, Winer E, Nilsson C, Dal Lago L, Korde L, Benstead K, Bogler O, Goulioti T, Peric A, Litière S, Aalders KC, Poncet C, Tryfonidis K, Giordano SH
Jaar : 2018
Journal : Ann Oncol
Volume : 29(2)
Pagina's : 405-417

Old age: An extra risk for febrile neutropenia?

Auteurs : Klastersky J, Dal Lago L
Jaar : 2017
Journal : J Geriatr Oncol
Volume : 8(2)
Pagina's : 84-85